Sort by
Refine Your Search
-
. The postdoc will develop machine learning algorithms to analyze phenotype and sequence data, as well as active learning algorithms to optimize and control experiments in directed evolution. This position
-
301.975.3792 Description Post-doctoral positions are available to advance materials, methods, and instrumentation for electron paramagnetic resonance (EPR) spectroscopy measurements of nanomaterials and
-
opportunities are available in developing integrated nanophotonic architectures and devices for realizing compact, efficient, accurate and dynamic quantum AMO systems-on-a-chip. By creating a set of scalable
-
, physical chemistry, and mesoscale physics. We employ a set of rigorous top-down methods, ranging from analytical theory calculations to large-scale atomistic and density functional theory simulations. A
-
5235 Andrew J. Slifka andrew.slifka@nist.gov 303.497.3744 Description As hydrogen-fueled technologies gain traction throughout the world, a better set of standards is needed to govern the building
-
. Compressive sensing is a new approach where incomplete sampling under certain circumstances can be used to accurately recover the full data set--roughly translated into more information from less data
-
opportunity location 50.64.61.C0054 Gaithersburg, MD NIST only participates in the February and August reviews. Advisers name email phone Benjamin J Place benjamin.place@nist.gov 301.975.3941 Description
-
on fundamental constants in the development of quantum electrical standards. The FEM group uses physical laws, quantum invariants, and ultra-precision measurement techniques to create and refine a core set of
-
of piconewton to nanonewton forces, there are a handful of phenomena already referred to as “force standards” in the single-molecule, bioforce literature. We intend to put these phenomena to the test; measuring
-
to alcohol consumption have been set and alcohol concentration in the breath is easily determined by non-invasive field tests. However, intoxication and thus, impairment indicators from other types of drugs